The clinical implications of increased OX40 ligand expression in patients with acute coronary syndrome

Clinica Chimica Acta

Volumn 397, Issue 1-2, 2008, Pages 22-26

  Liu, Dong Ming ^a   Yan, Jin Chuan ^a   Wang, Cui Ping ^a   Chen, Guang Hua ^a   Ding, Shu ^a   Liu, Pei Jin ^a   Du, Rong Zeng ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Acute coronary syndromes; Matrix metalloproteinases; OX40 ligand

Indexed keywords

GELATINASE B; OX40 LIGAND; STROMELYSIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE;

ACUTE CORONARY SYNDROME; AGED; BLOOD PLATELETS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OX40 LIGAND;

ANGINA;

EID: 51249097243     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.07.003     Document Type: Article

References (17)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Hansson G.K., and Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6 (2006) 508-519
3. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 (2006) 515-581
4. Ria M., Eriksson P., Boquist S., Ericsson C.G., Hamsten A., and Lagercrantz J. Human genetic evidence that OX40 is implicated in myocardial infarction. Biochem Biophys Res Commun 339 (2006) 1001-1006
5. Wang X., Ria M., Kelmenson P.M., et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet 37 (2005) 365-372
6. Goldstein J.A., Demetriou D., Grines C.L., Pica M., Shoukfeh M., and O'Neill W.W. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 28 (2000) 915-922
7. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger III A.L., and Furman M.I. Evaluation of platelet function by flow cytometry. Methods 21 (2000) 259-270
8. Kaski J.C., Chester M.R., Chen L., and Katritsis D. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 92 (1995) 2058-2065
9. Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32 (1998) 368-372
10. Inokubo Y., Hanada H., Ishizaka H., Fukushi T., Kamada T., and Okumura K. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome. Am Heart J 141 (2001) 211-217
11. van Wanrooij E.J., van Puijvelde G.H., de Vos P., Yagita H., van Berkel T.J., and Kuiper J. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 27 1 (2007) 204-210
12. Wilson R.F., Holida M.D., and White C.W. Quantitative angiographic morphology of coronary stenoses leading to myocardial infarction or unstable angina. Circulation 73 (1986) 286-293
13. Divies M.J. Stability and instability: two faces of coronary atherosclerosis. Circulation 94 (1996) 2013-2020
14. Schroeder A.P., and Falk E. Vulnerable and dangerous coronary plaques. Atherosclerosis 118 (1995) S141-S149
15. Higgins L.M., McDonald S.A., Whittle N., Crockett N., Shields J.G., and MacDonald T.T. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol 162 (1999) 486-493
16. Carboni S., Aboul-Enein F., Waltzinger C., Killeen N., Lassmann H., and Pena-Rossi C. CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J Neuroimmunol 145 (2003) 1-11
17. Nohara C., Akiba H., Nakajima A., et al. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J Immunol 166 (2001) 2108-2115